Logotipo do repositório
 

Publicação:
Engineered Vasculature for Cancer Research and Regenerative Medicine

dc.contributor.authorNguyen, Huu Tuan
dc.contributor.authorPeirsman, Arne
dc.contributor.authorTirpakova, Zuzana
dc.contributor.authorMandal, Kalpana
dc.contributor.authorVanlauwe, Florian
dc.contributor.authorMaity, Surjendu
dc.contributor.authorKawakita, Satoru
dc.contributor.authorKhorsandi, Danial
dc.contributor.authorHerculano, Rondinelli [UNESP]
dc.contributor.authorUmemura, Christian
dc.contributor.authorYilgor, Can
dc.contributor.authorBell, Remy
dc.contributor.authorHanson, Adrian
dc.contributor.authorLi, Shaopei
dc.contributor.authorNanda, Himansu Sekhar
dc.contributor.authorZhu, Yangzhi
dc.contributor.authorNajafabadi, Alireza Hassani
dc.contributor.authorJucaud, Vadim
dc.contributor.authorBarros, Natan
dc.contributor.authorDokmeci, Mehmet Remzi
dc.contributor.authorKhademhosseini, Ali
dc.contributor.institutionTerasaki Institute for Biomedical Innovation
dc.contributor.institutionGhent University Hospital
dc.contributor.institutionUniversity of Veterinary Medicine and Pharmacy in Kosice
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionPDPM—Indian Institute of Information Technology Design Manufacturing
dc.date.accessioned2023-07-29T13:17:07Z
dc.date.available2023-07-29T13:17:07Z
dc.date.issued2023-05-01
dc.description.abstractEngineered human tissues created by three-dimensional cell culture of human cells in a hydrogel are becoming emerging model systems for cancer drug discovery and regenerative medicine. Complex functional engineered tissues can also assist in the regeneration, repair, or replacement of human tissues. However, one of the main hurdles for tissue engineering, three-dimensional cell culture, and regenerative medicine is the capability of delivering nutrients and oxygen to cells through the vasculatures. Several studies have investigated different strategies to create a functional vascular system in engineered tissues and organ-on-a-chips. Engineered vasculatures have been used for the studies of angiogenesis, vasculogenesis, as well as drug and cell transports across the endothelium. Moreover, vascular engineering allows the creation of large functional vascular conduits for regenerative medicine purposes. However, there are still many challenges in the creation of vascularized tissue constructs and their biological applications. This review will summarize the latest efforts to create vasculatures and vascularized tissues for cancer research and regenerative medicine.en
dc.description.affiliationTerasaki Institute for Biomedical Innovation
dc.description.affiliationPlastic Reconstructive and Aesthetic Surgery Ghent University Hospital
dc.description.affiliationDepartment of Biology and Physiology University of Veterinary Medicine and Pharmacy in Kosice, Komenskeho 73
dc.description.affiliationBioengineering & Biomaterials Group School of Pharmaceutical Sciences São Paulo State University (UNESP), SP
dc.description.affiliationBiomedical Engineering and Technology Laboratory PDPM—Indian Institute of Information Technology Design Manufacturing, Madhya Pradesh
dc.description.affiliationUnespBioengineering & Biomaterials Group School of Pharmaceutical Sciences São Paulo State University (UNESP), SP
dc.description.sponsorshipFonds Wetenschappelijk Onderzoek
dc.description.sponsorshipCenter for Information Technology
dc.description.sponsorshipCenter for Scientific Review
dc.description.sponsorshipNational Institutes of Health
dc.description.sponsorshipOffice of Extramural Research, National Institutes of Health
dc.description.sponsorshipOffice of Research Infrastructure Programs, National Institutes of Health
dc.description.sponsorshipIdFonds Wetenschappelijk Onderzoek: 11M9322N
dc.description.sponsorshipIdCenter for Information Technology: R01 CA257558-01A1
dc.description.sponsorshipIdCenter for Scientific Review: R01 CA257558-01A1
dc.description.sponsorshipIdNational Institutes of Health: R01 CA257558-01A1
dc.description.sponsorshipIdOffice of Extramural Research, National Institutes of Health: R01 CA257558-01A1
dc.description.sponsorshipIdOffice of Research Infrastructure Programs, National Institutes of Health: R01 CA257558-01A1
dc.description.sponsorshipIdCenter for Information Technology: R01AR073135
dc.description.sponsorshipIdCenter for Scientific Review: R01AR073135
dc.description.sponsorshipIdNational Institutes of Health: R01AR073135
dc.description.sponsorshipIdOffice of Extramural Research, National Institutes of Health: R01AR073135
dc.description.sponsorshipIdOffice of Research Infrastructure Programs, National Institutes of Health: R01AR073135
dc.description.sponsorshipIdCenter for Information Technology: R01AR074234
dc.description.sponsorshipIdCenter for Scientific Review: R01AR074234
dc.description.sponsorshipIdNational Institutes of Health: R01AR074234
dc.description.sponsorshipIdOffice of Extramural Research, National Institutes of Health: R01AR074234
dc.description.sponsorshipIdOffice of Research Infrastructure Programs, National Institutes of Health: R01AR074234
dc.description.sponsorshipIdCenter for Information Technology: R01GM126571
dc.description.sponsorshipIdCenter for Scientific Review: R01GM126571
dc.description.sponsorshipIdNational Institutes of Health: R01GM126571
dc.description.sponsorshipIdOffice of Extramural Research, National Institutes of Health: R01GM126571
dc.description.sponsorshipIdOffice of Research Infrastructure Programs, National Institutes of Health: R01GM126571
dc.description.sponsorshipIdCenter for Information Technology: R34NS126032
dc.description.sponsorshipIdCenter for Scientific Review: R34NS126032
dc.description.sponsorshipIdNational Institutes of Health: R34NS126032
dc.description.sponsorshipIdOffice of Extramural Research, National Institutes of Health: R34NS126032
dc.description.sponsorshipIdOffice of Research Infrastructure Programs, National Institutes of Health: R34NS126032
dc.description.sponsorshipIdCenter for Information Technology: UH3TR003148
dc.description.sponsorshipIdCenter for Scientific Review: UH3TR003148
dc.description.sponsorshipIdNational Institutes of Health: UH3TR003148
dc.description.sponsorshipIdOffice of Extramural Research, National Institutes of Health: UH3TR003148
dc.description.sponsorshipIdOffice of Research Infrastructure Programs, National Institutes of Health: UH3TR003148
dc.identifierhttp://dx.doi.org/10.3390/mi14050978
dc.identifier.citationMicromachines, v. 14, n. 5, 2023.
dc.identifier.doi10.3390/mi14050978
dc.identifier.issn2072-666X
dc.identifier.scopus2-s2.0-85160624211
dc.identifier.urihttp://hdl.handle.net/11449/247478
dc.language.isoeng
dc.relation.ispartofMicromachines
dc.sourceScopus
dc.subjectcancer
dc.subjectengineered vasculature
dc.subjectmicrofluidics
dc.subjectorgan-on-a-chip
dc.subjectregenerative medicine
dc.titleEngineered Vasculature for Cancer Research and Regenerative Medicineen
dc.typeResenhapt
dspace.entity.typePublication
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.author.orcid0000-0002-6519-8367[2]
unesp.author.orcid0000-0003-0190-248X[6]
unesp.author.orcid0009-0000-9214-4324[11]
unesp.author.orcid0000-0002-4737-6553[12]
unesp.author.orcid0000-0003-0385-2623[18]
unesp.author.orcid0000-0002-2692-1524[21]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt

Arquivos